Position in ASND
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$52,671,486
+$12,808,401 QoQ
Shares Held
230,278
+23.2% QoQ
Ownership
0.351%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
195,674 | $122,010,565 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
556,392 | $104,201,093 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
199,505 | $99,100,118 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
314,512 | $94,677,547 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
289,735 | $82,565,782 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
2,088,369 | $80,819,880 | |
| 7 | ARGX |
Argenx SE
|
80,120 | $74,332,932 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,990,510 | $70,444,148 |
All Filings in ASND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $52,671,486 | 230,278 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $39,863,085 | 186,940 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $35,578,242 | 178,956 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $33,676,849 | 195,115 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $37,836,729 | 242,761 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $38,568,801 | 280,154 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $42,154,841 | 282,331 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $26,641,423 | 195,347 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $15,022,518 | 99,375 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $12,516,281 | 99,375 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,051,075 | 139,375 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $13,242,468 | 148,375 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $26,845,207 | 250,375 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,250,498 | 190,375 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $21,310,282 | 206,375 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $20,521,012 | 220,751 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $19,284,360 | 164,318 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $32,074,911 | 238,422 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $39,911,096 | 250,399 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $37,226,019 | 282,980 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $31,017,678 | 240,671 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $40,139,109 | 240,671 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $41,524,271 | 269,079 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $28,112,684 | 190,079 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $12,612,320 | 112,000 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||